SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-044948
Filing Date
2013-09-19
Accepted
2013-09-19 19:32:35
Documents
2
Period of Report
2013-09-19

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c598609_3x1.html 3  
1 MAIN DOCUMENT DESCRIPTION c598609_3x1.xml 3 3914
2 POWER OF ATTORNEY c598609_24.htm EX-24 5153
  Complete submission text file 0001209191-13-044948.txt   10472
Mailing Address
Business Address
LYNCH DANIEL (Reporting) CIK: 0001177082 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36072 | Film No.: 131106477

Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Issuer) CIK: 0001385228 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations